These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8081838)

  • 1. Structure-activity studies of endothelin leading to novel peptide ETA antagonists.
    Hunt JT; Lee VG; McMullen D; Liu EC; Bolgar M; Delaney CL; Festin SM; Floyd DM; Hedberg A; Natarajan S
    Bioorg Med Chem; 1993 Jul; 1(1):59-65. PubMed ID: 8081838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor binding affinity of monocyclic [Ala3,Xaa11]endothelin-1 analogs correlates with inducible helix length.
    Andersen NH; Harris SM; Lee VG; Liu EC; Moreland S; Hunt JT
    Bioorg Med Chem; 1995 Feb; 3(2):113-24. PubMed ID: 7796045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
    Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin analogs which distinguish vasoconstrictor and vasodilator ETB receptors.
    Natarajan S; Hunt JT; Festin S; Serafino R; Zhang R; Moreland S
    Life Sci; 1995 Mar; 56(15):1251-6. PubMed ID: 8614242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21).
    Urade Y; Fujitani Y; Oda K; Watakabe T; Umemura I; Takai M; Okada T; Sakata K; Karaki H
    FEBS Lett; 1992 Oct; 311(1):12-6. PubMed ID: 1397285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.
    Doherty AM; Cody WL; DePue PL; He JX; Waite LA; Leonard DM; Leitz NL; Dudley DT; Rapundalo ST; Hingorani GP
    J Med Chem; 1993 Sep; 36(18):2585-94. PubMed ID: 8410970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of endothelin-1-receptor subtypes in rat portal vein.
    Filippelli A; Falciani M; Palla A; D'Amico M; Vacca C; Rossi F
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):113-18. PubMed ID: 8656643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
    J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
    Kikuchi T; Kubo K; Ohtaki T; Suzuki N; Asami T; Shimamoto N; Wakimasu M; Fujino M
    J Med Chem; 1993 Dec; 36(25):4087-93. PubMed ID: 8258832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle.
    Lodge NJ; Zhang R; Halaka NN; Moreland S
    Eur J Pharmacol; 1995 Dec; 287(3):279-85. PubMed ID: 8991802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of 125I-endothelin-1 and 125I-endothelin-3 in rabbit saphenous vein: evidence for an atypical ET binding component.
    Liu EC; Monshizadegan H; Chao CC; Lynch J; Fisher SM; Rose PM; Webb ML
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S132-5. PubMed ID: 7509924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype.
    Ihara M; Yamanaka R; Ohwaki K; Ozaki S; Fukami T; Ishikawa K; Towers P; Yano M
    Eur J Pharmacol; 1995 Feb; 274(1-3):1-6. PubMed ID: 7768260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human endothelin ETA receptor antisense oligodeoxynucleotides inhibit endothelin-1 evoked vasoconstriction.
    Adner M; Erlinge D; Salford LG; Yee F; Wahlestedt C; Edvinsson L
    Eur J Pharmacol; 1994 Aug; 261(3):281-4. PubMed ID: 7813549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 and the regulation of vascular tone.
    La M; Reid JJ
    Clin Exp Pharmacol Physiol; 1995 May; 22(5):315-23. PubMed ID: 7554421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.
    Heyl DL; Cody WL; He JX; Flynn MA; Welch KM; Reynolds EE; Doherty AM
    Pept Res; 1993; 6(5):238-41. PubMed ID: 8257799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
    Webb ML; Bird JE; Liu EC; Rose PM; Serafino R; Stein PD; Moreland S
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1124-34. PubMed ID: 7891325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
    Seo B; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.
    Doherty AM; Cody WL; He JX; DePue PL; Cheng XM; Welch KM; Flynn MA; Reynolds EE; LaDouceur DM; Davis LS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S98-102. PubMed ID: 7510009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.